COVID Convalescent Whole Blood, Fresh

COVID-19 convalescent primary human whole blood collected from recovered donors, fresh

More Views

From: 1,199 USD

Options

* Required Fields

Catalog # (Select a product)
COVID-19 convalescent primary human whole blood collected from recovered donors, fresh
From: 1,199 USD

The FDA recently announced an Emergency Use Authorization for convalescent plasma for the treatment of COVID19. However, it is critical to note that COVID Convalescent Whole Blood (Catalog #s 200-0129, 200-0140, 200-0141) does not meet the baseline regulatory requirements for clinical applications and is not safe for human administration under any circumstances.

Overview

Whole peripheral blood (PB) was obtained from COVID-19 recovered donors using Institutional Review Board (IRB)-approved consent forms and protocols.

Certain products are only available in select territories. Please contact your local Sales representative or Product & Scientific Support at techsupport@stemcell.com for further information and to inquire about donor selection or information including BMI category, smoking status, ethnicity, etc.

Browse our Frequently Asked Questions (FAQs) on Primary Cells.
Subtype:
Fresh
Cell Type:
Whole
Species:
Human
Cell and Tissue Source:
Peripheral Blood
Donor Status:
Diseased

Scientific Resources

Product Documentation

Document Type
Product Name
Catalog #
Lot #
Language

Product Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. FOR ADDITIONAL INFORMATION ON QUALITY AT STEMCELL, REFER TO WWW.STEMCELL.COM/COMPLIANCE.